Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion type Assertion NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_head.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion description "[This study was designed (1) to determine the plasma levels of progastrin and amidated gastrin in 50 CRC patients before and 3-6 months after removal of the tumor, (2) to determine the tumor concentrations of these gastrin peptides and the level of expression for gastrin mRNA and gastrin/CCK(B) receptor mRNA, (3) to examine the expression of cyclooxygenase COX-1 and COX-2 mRNA in CRC tissue, and (4) to compare the prevalence of Hp and its cytotoxic protein, CagA, and cytokines (TNFalpha, IL-1beta, and IL-8) in CRCs, before and after removal of tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_provenance.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion evidence source_evidence_literature NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_provenance.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion SIO_000772 12353842 NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_provenance.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion wasDerivedFrom befree-20140225 NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_provenance.
- NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_assertion wasGeneratedBy ECO_0000203 NP688718.RA_ZScHLHsFqFIdDDxozusi-mkHTauG8k1TxfOym9g0MA130_provenance.